161 related articles for article (PubMed ID: 37369132)
41. Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP.
Taskinen M; Valo E; Karjalainen-Lindsberg ML; Hautaniemi S; Meri S; Leppä S
Clin Cancer Res; 2010 May; 16(9):2615-23. PubMed ID: 20388848
[TBL] [Abstract][Full Text] [Related]
42. STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease.
Li G; Miskimen KL; Wang Z; Xie XY; Brenzovich J; Ryan JJ; Tse W; Moriggl R; Bunting KD
Blood; 2010 Feb; 115(7):1416-24. PubMed ID: 20008792
[TBL] [Abstract][Full Text] [Related]
43. Pharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer.
Gu L; Liao Z; Hoang DT; Dagvadorj A; Gupta S; Blackmon S; Ellsworth E; Talati P; Leiby B; Zinda M; Lallas CD; Trabulsi EJ; McCue P; Gomella L; Huszar D; Nevalainen MT
Clin Cancer Res; 2013 Oct; 19(20):5658-74. PubMed ID: 23942095
[TBL] [Abstract][Full Text] [Related]
44. STAT5A modulates gastric cancer progression via upregulation of CD44.
Wang S; Fan R; Gao H; Ma X; Wu Y; Xing Y; Wang Y; Jia Y
Genomics; 2023 May; 115(3):110638. PubMed ID: 37196931
[TBL] [Abstract][Full Text] [Related]
45. Expression and prognostic significance of Stat5a and E-cadherin in extramammary Paget's disease.
Liu H; Urabe K; Uchi H; Takeuchi S; Nakahara T; Dainichi T; Tu Y; Furue M; Moroi Y
J Cutan Pathol; 2007 Jan; 34(1):33-8. PubMed ID: 17214852
[TBL] [Abstract][Full Text] [Related]
46. A Bioinformatic Pipeline Places STAT5A as a miR-650 Target in Poorly Differentiated Aggressive Breast Cancer.
López-Huerta E; Fuentes-Pananá EM
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33086498
[TBL] [Abstract][Full Text] [Related]
47. Role of STAT5a in regulation of sex-specific gene expression in female but not male mouse liver revealed by microarray analysis.
Clodfelter KH; Miles GD; Wauthier V; Holloway MG; Zhang X; Hodor P; Ray WJ; Waxman DJ
Physiol Genomics; 2007 Sep; 31(1):63-74. PubMed ID: 17536022
[TBL] [Abstract][Full Text] [Related]
48. Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia.
Liao Z; Gu L; Vergalli J; Mariani SA; De Dominici M; Lokareddy RK; Dagvadorj A; Purushottamachar P; McCue PA; Trabulsi E; Lallas CD; Gupta S; Ellsworth E; Blackmon S; Ertel A; Fortina P; Leiby B; Xia G; Rui H; Hoang DT; Gomella LG; Cingolani G; Njar V; Pattabiraman N; Calabretta B; Nevalainen MT
Mol Cancer Ther; 2015 Aug; 14(8):1777-93. PubMed ID: 26026053
[TBL] [Abstract][Full Text] [Related]
49. Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2(V617F) in mice.
Walz C; Ahmed W; Lazarides K; Betancur M; Patel N; Hennighausen L; Zaleskas VM; Van Etten RA
Blood; 2012 Apr; 119(15):3550-60. PubMed ID: 22234689
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.
Liu S; Foulkes WD; Leung S; Gao D; Lau S; Kos Z; Nielsen TO
Breast Cancer Res; 2014 Sep; 16(5):432. PubMed ID: 25193543
[TBL] [Abstract][Full Text] [Related]
51. STAT5 requires the N-domain to maintain hematopoietic stem cell repopulating function and appropriate lymphoid-myeloid lineage output.
Li G; Wang Z; Zhang Y; Kang Z; Haviernikova E; Cui Y; Hennighausen L; Moriggl R; Wang D; Tse W; Bunting KD
Exp Hematol; 2007 Nov; 35(11):1684-94. PubMed ID: 17976521
[TBL] [Abstract][Full Text] [Related]
52. STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1.
Li Z; Chen C; Chen L; Hu D; Yang X; Zhuo W; Chen Y; Yang J; Zhou Y; Mao M; Zhang X; Xu L; Ju S; Shen J; Wang Q; Dong M; Xie S; Wei Q; Jia Y; Zhou J; Wang L
Front Oncol; 2021; 11():697950. PubMed ID: 34336684
[TBL] [Abstract][Full Text] [Related]
53. STAT5A and STAT5B have opposite correlations with drug response gene expression.
Lamba V; Jia B; Liang F
Biochem Biophys Res Commun; 2016 Oct; 479(2):117-124. PubMed ID: 27264955
[TBL] [Abstract][Full Text] [Related]
54. Peroxisome proliferator-activated receptor gamma regulates expression of signal transducer and activator of transcription 5A.
Olsen H; Haldosén LA
Exp Cell Res; 2006 May; 312(8):1371-80. PubMed ID: 16457814
[TBL] [Abstract][Full Text] [Related]
55. A point mutation in the linker domain of mouse STAT5A is associated with impaired NK-cell regulation.
Chehboun S; Leiva-Torres GA; Charbonneau B; Eveleigh R; Bourque G; Vidal SM
Genes Immun; 2020 Feb; 21(2):136-141. PubMed ID: 31591503
[TBL] [Abstract][Full Text] [Related]
56. STAT5A/B gene locus undergoes amplification during human prostate cancer progression.
Haddad BR; Gu L; Mirtti T; Dagvadorj A; Vogiatzi P; Hoang DT; Bajaj R; Leiby B; Ellsworth E; Blackmon S; Ruiz C; Curtis M; Fortina P; Ertel A; Liu C; Rui H; Visakorpi T; Bubendorf L; Lallas CD; Trabulsi EJ; McCue P; Gomella L; Nevalainen MT
Am J Pathol; 2013 Jun; 182(6):2264-75. PubMed ID: 23660011
[TBL] [Abstract][Full Text] [Related]
57. Stat5a increases lactation of dairy cow mammary gland epithelial cells cultured in vitro.
Liu XF; Li M; Li QZ; Lu LM; Tong HL; Gao XJ
In Vitro Cell Dev Biol Anim; 2012 Oct; 48(9):554-61. PubMed ID: 23054437
[TBL] [Abstract][Full Text] [Related]
58. miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions.
Pinatel EM; Orso F; Penna E; Cimino D; Elia AR; Circosta P; Dentelli P; Brizzi MF; Provero P; Taverna D
PLoS One; 2014; 9(1):e84859. PubMed ID: 24400121
[TBL] [Abstract][Full Text] [Related]
59. STAT5a and STAT6 gene expression levels in multiple sclerosis patients.
Hatami M; Salmani T; Arsang-Jang S; Davood Omrani M; Mazdeh M; Ghafouri-Fard S; Sayad A; Taheri M
Cytokine; 2018 Jun; 106():108-113. PubMed ID: 29126764
[TBL] [Abstract][Full Text] [Related]
60. Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer.
Yamashita H; Nishio M; Ando Y; Zhang Z; Hamaguchi M; Mita K; Kobayashi S; Fujii Y; Iwase H
Endocr Relat Cancer; 2006 Sep; 13(3):885-93. PubMed ID: 16954437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
